NEWS LETTER Awareness of the ambivalence of scientific Deep Brain Stimulation Neuromodulation Therapies for Psychiatric Disorder and their Ethical Implicationsconsiderably over the last few decades. Prob-lems associated with scientific and technologi- Depression refers to a set of prevalent, extremely debilitating disorders that can be character- cal advancement and their possible but so
ImmusanT Names Ferdinand E. Massari as Chief Medical Officer CAMBRIDGE, Mass., September 9, 2013 – ImmusanT announced today that Ferdinand E. Massari, MD has joined the biopharmaceutical company as Senior Vice President, Development and Chief Medical Officer. Dr. Massari will oversee the clinical development program for the therapeutic vaccine Nexvax2® for celiac disease and its c